Dry eye disease (DED) is a multifactorial disease of the ocular surface system whose chore
mechanisms are tear film instability, inflammation, tear hyperosmolarity and epithelial
damage. In recent years, novel therapies specifically targeting inflammation and oxidative
stress are being investigated and used in this field. Therefore, an increasing body of
evidence supporting the possible role of different micronutrients and nutraceutical products
for the treatment of ocular surface diseases is now available. In the present review, we …